Xu Hu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Xu Hu has a total of 68 co-authors. Here are the top co-authors by number of shared publications:
- Mingliang Zhang
Department of Histoembryology, Genetics and Developmental Biology, Shanghai Key Laboratory of Reproductive Medicine, Shanghai Jiao Tong University School of Medicine , Shanghai 200025
2 shared publications - Boyu Zhang
College of Medical Laboratory, Dalian Medical University, Dalian 116044, China
1 shared publication Chang Liu
Department of Histoembryology, Genetics and Developmental Biology, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Reproductive Medicine, Shanghai, China
1 shared publicationChao Gao
Huashan Hospital, Fudan University, and Molecular and Cell Biology Lab, the Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, and the Key Laboratory of Metabolism and Molecular, Ministry of Education, Shanghai, China; The International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Beijing, China
1 shared publicationChen Yang
Key Laboratory of Synthetic Biology, Institute of Plant Physiology and Ecology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, Shanghai 200032, China
1 shared publicationCheng Zhang
Huashan Hospital, Fudan University, and Molecular and Cell Biology Lab, the Shanghai Key Laboratory of Medical Epigenetics, Institutes of Biomedical Sciences, Fudan University, and the Key Laboratory of Metabolism and Molecular, Ministry of Education, Shanghai, China; The International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Beijing, China
1 shared publication
Latest Publications
- Open Access
- 23 October 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (12) , 113689
FAT1 generates a nuclear fragment that impairs DNA damage repair in gastric cancer
- 23 October 2026
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 302 (12) , 113689
Open AccessFAT1 generates a nuclear fragment that impairs DNA damage repair in gastric cancer
- 27 June 2025
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 41 (8) , 463-474
Minichromosome Maintenance Complex Genes Are Candidate Biomarkers of Retinal Degeneration
Purpose: Retinal degeneration is the primary cause of blindness and is characterized by progressive dysfunction and death of retinal cells, leading to irreversible vision impairment. As far as is known, there are currently no effective treatments for this condition. The identification of novel therapeutic targets remains a critical challenge. Methods: To address this vital issue, we performed an in-depth transcriptome analysis of the sodium iodate-induced cell model (NaIO 3 -treated cells), further identified the differential gene expression and common pathways, performed enrichment analysis, constructed protein–protein interaction (PPI) networks, and screened for three core DNA replication-related genes ( MCM4 , MCM5 , and MCM7 ). Subsequently, quantitative real-time polymerase chain reaction (qPCR) and immunohistochemistry assays were performed to verify the expression levels of hub genes in the NaIO 3 -treated adult retinal pigment epithelial cell line-19 and animal models. Results: The pathways were mainly focused on DNA replication in the enrichment analysis. PPI network analysis revealed that minichromosome maintenance complex genes associated with DNA replication were core genes for retinal degeneration. qPCR and immunohistochemistry assays showed that the expression levels of hub genes were downregulated in the NaIO 3 -treated cell and animal models. Conclusions: Collectively, our bioinformatics analysis, coupled with experimental validation, identified three core DNA replication-related genes ( MCM4 , MCM5 , and MCM7 ) with potential implications in retinal degeneration, suggesting their roles in the disease process. These findings shed light on the molecular underpinnings of retinal degeneration and pave the way for the development of targeted therapies aimed at modulating DNA replication-related gene activity to treat retinal degeneration.
- 27 June 2025
- Published by SAGE Publications in Journal of Ocular Pharmacology and Therapeutics
- Vol. 41 (8) , 463-474
Minichromosome Maintenance Complex Genes Are Candidate Biomarkers of Retinal Degeneration
Purpose: Retinal degeneration is the primary cause of blindness and is characterized by progressive dysfunction and death of retinal cells, leading to irreversible vision impairment. As far as is known, there are currently no effective treatments for this condition. The identification of novel therapeutic targets remains a critical challenge. Methods: To address this vital issue, we performed an in-depth transcriptome analysis of the sodium iodate-induced cell model (NaIO 3 -treated cells), further identified the differential gene expression and common pathways, performed enrichment analysis, constructed protein–protein interaction (PPI) networks, and screened for three core DNA replication-related genes ( MCM4 , MCM5 , and MCM7 ). Subsequently, quantitative real-time polymerase chain reaction (qPCR) and immunohistochemistry assays were performed to verify the expression levels of hub genes in the NaIO 3 -treated adult retinal pigment epithelial cell line-19 and animal models. Results: The pathways were mainly focused on DNA replication in the enrichment analysis. PPI network analysis revealed that minichromosome maintenance complex genes associated with DNA replication were core genes for retinal degeneration. qPCR and immunohistochemistry assays showed that the expression levels of hub genes were downregulated in the NaIO 3 -treated cell and animal models. Conclusions: Collectively, our bioinformatics analysis, coupled with experimental validation, identified three core DNA replication-related genes ( MCM4 , MCM5 , and MCM7 ) with potential implications in retinal degeneration, suggesting their roles in the disease process. These findings shed light on the molecular underpinnings of retinal degeneration and pave the way for the development of targeted therapies aimed at modulating DNA replication-related gene activity to treat retinal degeneration.
- 23 January 2023
- Published by Elsevier in Coordination Chemistry Reviews
- Vol. 480, 215040
The chronological evolution of fluorescent GPCR probes for bioimaging
- 23 January 2023
- Published by Elsevier in Coordination Chemistry Reviews
- Vol. 480, 215040
The chronological evolution of fluorescent GPCR probes for bioimaging
- Open Access
- 1 July 2020
- Published by Elsevier in Cell Reports
- Vol. 32 (2) , 107877
The Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming
- 1 July 2020
- Published by Elsevier in Cell Reports
- Vol. 32 (2) , 107877
Open AccessThe Zscan4-Tet2 Transcription Nexus Regulates Metabolic Rewiring and Enhances Proteostasis to Promote Reprogramming
- Open Access
- 10 January 2019
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 11 (6) , 489-495
Conversion of mouse fibroblasts into oligodendrocyte progenitor-like cells through a chemical approach
Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising way for treating demyelinating diseases. However, generation of scalable and autologous sources of OPCs has proven difficult. We previously established a chemical condition M9 that could specifically initiate neural program in mouse embryonic fibroblasts. Here we found that M9 could induce the formation of colonies that undergo mesenchymal-to-epithelial transition at the early stage of reprogramming. These colonies may represent unstable and neural lineage-restricted intermediates that have not established a neural stem cell identity. By modulating the culture signaling recapitulating the principle of OPC development, these intermediate cells could be reprogrammed towards OPC fate. The chemical-induced OPC-like cells (ciOPLCs) resemble primary neural stem cell-derived OPCs in terms of their morphology, gene expression, and the ability of self-renewal. Upon differentiation, ciOPLCs could produce functional oligodendrocytes and myelinate the neuron axons in vitro, validating their OPC identity molecularly and functionally. Therefore, our study provides a non-integrating approach to OPC reprogramming that may ultimately provide an avenue to patient-specific cell-based or in situ regenerative therapy.
- 10 January 2019
- Published by Oxford University Press (OUP) in Journal of Molecular Cell Biology
- Vol. 11 (6) , 489-495
Open AccessConversion of mouse fibroblasts into oligodendrocyte progenitor-like cells through a chemical approach
Transplantation of oligodendrocyte progenitor cells (OPCs) is a promising way for treating demyelinating diseases. However, generation of scalable and autologous sources of OPCs has proven difficult. We previously established a chemical condition M9 that could specifically initiate neural program in mouse embryonic fibroblasts. Here we found that M9 could induce the formation of colonies that undergo mesenchymal-to-epithelial transition at the early stage of reprogramming. These colonies may represent unstable and neural lineage-restricted intermediates that have not established a neural stem cell identity. By modulating the culture signaling recapitulating the principle of OPC development, these intermediate cells could be reprogrammed towards OPC fate. The chemical-induced OPC-like cells (ciOPLCs) resemble primary neural stem cell-derived OPCs in terms of their morphology, gene expression, and the ability of self-renewal. Upon differentiation, ciOPLCs could produce functional oligodendrocytes and myelinate the neuron axons in vitro, validating their OPC identity molecularly and functionally. Therefore, our study provides a non-integrating approach to OPC reprogramming that may ultimately provide an avenue to patient-specific cell-based or in situ regenerative therapy.
- Open Access
- 1 January 2017
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 31 (3) , 213-225
Association of three single nucleotide polymorphisms of ESR1 with breast cancer susceptibility: a meta-analysis
Expression of estrogen receptors is correlated with breast cancer risk, but inconsistent results have been reported. To clarify potential estrogen receptor (ESR)-related breast cancer risk, we analyzed genetic variants ofESR1 in association with breast cancer susceptibility. We performed a meta-analysis to investigate the association between rs2234693, rs1801132, and rs2046210 (single nucleotide polymorphisms ofESR1), and breast cancer risk. Our analysis included 44 case-control studies. For rs2234693, the CC genotype had a higher risk of breast cancer compared to the TT or CT genotype. For rs2046210, the AA, GA, or GA+ GG genotype had a much higher risk compared to the GG genotype. No significant association was found for the rs1801132 polymorphism with breast cancer risk. This meta-analysis demonstrates association between the rs2234693 and rs2046210 polymorphisms ofESR1 and breast cancer risk. The correlation strength between rs2234693 and breast cancer susceptibility differs in subgroup assessment by ethnicity.
- 1 January 2017
- Published by Journal of Biomedical Research in Journal of Biomedical Research
- Vol. 31 (3) , 213-225
Open AccessAssociation of three single nucleotide polymorphisms of ESR1 with breast cancer susceptibility: a meta-analysis
Expression of estrogen receptors is correlated with breast cancer risk, but inconsistent results have been reported. To clarify potential estrogen receptor (ESR)-related breast cancer risk, we analyzed genetic variants ofESR1 in association with breast cancer susceptibility. We performed a meta-analysis to investigate the association between rs2234693, rs1801132, and rs2046210 (single nucleotide polymorphisms ofESR1), and breast cancer risk. Our analysis included 44 case-control studies. For rs2234693, the CC genotype had a higher risk of breast cancer compared to the TT or CT genotype. For rs2046210, the AA, GA, or GA+ GG genotype had a much higher risk compared to the GG genotype. No significant association was found for the rs1801132 polymorphism with breast cancer risk. This meta-analysis demonstrates association between the rs2234693 and rs2046210 polymorphisms ofESR1 and breast cancer risk. The correlation strength between rs2234693 and breast cancer susceptibility differs in subgroup assessment by ethnicity.